(Q37904385)

English

Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases

scientific article published on July 1, 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

vector-borne disease

0 references

0 references

author name string

Lionel Galibert

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Otto-Wilhelm Merten

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21784234

7 December 2024

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

July 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21784234

7 December 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0022201111000814?httpAccept=text/xml

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

https://api.elsevier.com/content/article/PII:S0022201111000814?httpAccept=text/plain

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Journal of Invertebrate Pathology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

107 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

S80-93

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production

1

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations

2

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells

3

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Bioprocessing of baculovirus vectors: a review

4

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Improving AAV vector yield in insect cells by modulating the temperature after infection.

5

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Effect of gene therapy on visual function in Leber's congenital amaurosis

6

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Insect cell physiology

9

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Function and genetics of dystrophin and dystrophin-related proteins in muscle

10

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity

11

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Improving rAAV production and purification: towards the definition of a scaleable process

12

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids

13

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

14

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Chimeric parvovirus B19 capsids for the presentation of foreign epitopes

15

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Parvovirus diagnostics and vaccine production in insect cells.

17

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Use of the baculovirus expression system for the generation of virus-like particles

18

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Reproducible High Yields of Recombinant Adeno-Associated Virus Produced Using Invertebrate Cells in 0.02- to 200-Liter Cultures

19

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Intron splicing-mediated expression of AAV Rep and Cap genes and production of AAV vectors in insect cells

22

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles

24

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors

25

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A helper virus-free packaging system for recombinant adeno-associated virus vectors

26

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Baculovirus expression vectors for insect and mammalian cells

27

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

28

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap

29

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Production of a novel influenza vaccine using insect cells: protection against drifted strains

30

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.

31

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

32

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

33

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells

34

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Enhanced growth of Sf-9 cells to a maximum density of 5.2 x 10(7) cells per mL and production of beta-galactosidase at high cell density by fed batch culture

35

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

36

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.

37

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors

38

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-beta-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells

39

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus

42

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

43

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.

44

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Clades of Adeno-associated viruses are widely disseminated in human tissues.

45

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

New recombinant serotypes of AAV vectors.

46

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

47

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

48

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

49

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

50

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Novel tools for production and purification of recombinant adenoassociated virus vectors

51

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses

52

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

53

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Clinical gene transfer studies for hemophilia B.

55

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells

56

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Baculovirus expression systems for recombinant protein production in insect cells

57

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Genetic modification of a baculovirus vector for increased expression in insect cells.

58

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters

59

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Autologous transplantation of SM/C-2.6(+) satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice.

61

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Insect cell culture for industrial production of recombinant proteins.

62

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Baculovirus-insect cell expression systems.

63

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins

64

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions

65

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes

66

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

67

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

69

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system

70

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Detection and analysis of Autographa californica nuclear polyhedrosis virus mutants with defective interfering properties

71

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Site-specific integration by adeno-associated virus

73

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Generation and analysis of defective genomes of Autographa californica nuclear polyhedrosis virus

74

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Role for highly regulated rep gene expression in adeno-associated virus vector production

75

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles

76

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus

77

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines

78

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

79

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

80

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

DNA structure modulates the oligomerization properties of the AAV initiator protein Rep68.

81

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system.

82

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals.

83

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Recombinant adeno-associated viral vector production using stable packaging and producer cell lines

84

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Adeno-associated virus vectors can be efficiently produced without helper virus

85

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

The adenovirus E1A and E1B19K genes provide a helper function for transfection-based adeno-associated virus vector production

86

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Development of a novel recombinant influenza vaccine in insect cells.

87

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Human cytomegalovirus completely helps adeno-associated virus replication

88

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Purification of recombinant rotavirus VP7 glycoprotein for the study of in vitro rotavirus-like particles assembly

89

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Improving adeno-associated vector yield in high density insect cell cultures

91

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles

92

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Current issues in adeno-associated viral vector production

94

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus

95

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene

96

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein

97

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Exon-skipping therapy for Duchenne muscular dystrophy

98

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system

99

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study

100

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle

101

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Towards gene therapy for Parkinson's disease

102

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Utilization of oxygen uptake rate to assess the role of glucose and glutamine in the metabolism of infected insect cell cultures

103

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Scalable production of adeno-associated virus type 2 vectors via suspension transfection

104

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection

105

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells

106

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Cell line-specific accumulation of the baculovirus non-hr origin of DNA replication in infected insect cells

107

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Pivotal role of the non-hr origin of DNA replication in the genesis of defective interfering baculoviruses

108

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes

109

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines

110

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Alternative polyadenylation of adeno-associated virus type 5 RNA within an internal intron is governed by the distance between the promoter and the intron and is inhibited by U1 small nuclear RNP binding to the intervening donor

111

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

113

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy

114

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells

115

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2

116

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Factors influencing recombinant adeno-associated virus production

117

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

118

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells

119

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

121

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus

122

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity

123

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein

125

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration

126

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells

127

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A viral assembly factor promotes AAV2 capsid formation in the nucleolus

128

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Nucleotide sequence and organization of the adeno-associated virus 2 genome

129

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Effect of elevated oxygen and glutamine levels on foreign protein production at high cell densities using the insect cell-baculovirus expression system

130

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells

131

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells

133

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Mechanisms of adeno-associated virus genome encapsidation

134

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Discrimination between different types of human adeno-associated viruses in clinical samples by PCR

135

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines

136

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function

137

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells

138

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Insect cells as a factory to produce adeno-associated virus type 2 vectors

139

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Continuous beta-galactosidase production with a recombinant baculovirus insect-cell system in bioreactors

141

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Vaccines for viral and parasitic diseases produced with baculovirus vectors

142

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Opportunities and challenges for the baculovirus expression system

143

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Purification of recombinant baculoviruses for gene therapy using membrane processes.

144

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Large-scale production and purification of VLP-based vaccines

145

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy

146

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

147

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Treatment of human disease by adeno-associated viral gene transfer

148

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication

149

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA

150

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

PTC124 targets genetic disorders caused by nonsense mutations

151

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system

152

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Subcellular compartmentalization of adeno-associated virus type 2 assembly

153

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Adeno-associated virus serotypes: vector toolkit for human gene therapy

154

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap.

155

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype

158

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

A mathematical model of baculovirus infection on insect cells at low multiplicity of infection

160

1 reference

10.1016/J.JIP.2011.05.008

https://api.crossref.org/works/10.1016/J.JIP.2011.05.008

7 December 2024

Identifiers

10.1016/J.JIP.2011.05.008

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

release_myrafws54nay7orpkodaefzsle

1 reference

https://api.fatcat.wiki/v0/release/myrafws54nay7orpkodaefzsle

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37904385&oldid=2284681360"